IPINTL LLC has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Australia, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals are AVIVE INC, CHENGDU OLYMVAX BIOPHARMACEUTICALS CO LTD and ARRIGO CLAUDIO D.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | China | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Mexico | 1 | |
#8 | Malaysia | 1 | |
#9 | New Zealand | 1 | |
#10 | Singapore | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Chen Chien-Hung | 13 |
#2 | Chien-Hung Chen | 3 |
Publication | Filing date | Title |
---|---|---|
AU2014200497A1 | Novel Composition for Treating Metabolic Syndrome | |
CN102395359A | Treating alzheimer's disease and osteoporosis and reducing aging | |
MX2009007720A | Novel composition for treating metabolic syndrome. |